Company Nordpharm Ab S.r.l. with Fiscal Code 5285383
recorded a turnover of 2024 of
1.752.883,
with a net profit of
-82.990
and having an average number of employees of
15.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Nordpharm Ab S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
1.586.757
1.444.958
1.323.958
1.233.409
1.324.184
1.417.156
1.489.618
1.586.393
1.801.491
1.752.883
Total Income - EUR
1.586.795
1.445.087
1.324.638
1.248.851
1.324.559
1.417.211
1.489.719
1.590.599
1.801.514
1.770.105
Total Expenses - EUR
1.555.988
1.433.976
1.331.176
1.250.335
1.328.978
1.412.944
1.476.847
1.584.649
1.794.798
1.853.095
Gross Profit/Loss - EUR
30.807
11.111
-6.539
-1.484
-4.419
4.267
12.872
5.950
6.716
-82.990
Net Profit/Loss - EUR
22.841
2.319
-8.803
-4.967
-7.142
1.501
8.321
1.703
2.769
-82.990
Employees
10
12
14
17
16
19
18
17
14
15
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -2.2%, from 1.801.491 euro in the year 2023, to 1.752.883 euro in 2024.
The Net Profit decreased by -2.754 euro, from 2.769 euro in 2023, to 0 in the last year.
Check the financial reports for the company - Nordpharm Ab S.r.l.
Financial Rating - NORDPHARM AB S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Nordpharm Ab S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Nordpharm Ab S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Nordpharm Ab S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Nordpharm Ab S.r.l. - CUI 5285383
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
57.582
82.615
68.026
53.594
50.316
37.947
38.892
29.143
23.042
7.572
Current Assets
545.009
481.727
514.252
523.169
527.536
586.014
605.346
715.002
731.285
474.461
Inventories
279.496
367.702
375.003
346.333
385.675
408.986
396.293
436.475
432.340
176.342
Receivables
136.537
18.129
81.716
155.056
132.839
166.581
174.211
267.028
266.629
265.748
Cash
128.976
95.896
57.532
21.779
9.022
10.447
34.841
11.500
32.316
32.371
Shareholders Funds
163.094
161.497
133.006
110.986
83.993
66.535
56.401
33.540
16.153
-77.974
Social Capital
49
49
48
47
46
45
44
45
44
44
Debts
445.135
408.067
454.406
470.817
498.801
562.274
592.578
715.361
742.915
560.006
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4773 - 4773"
CAEN Financial Year
4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
474.461 euro in 2024 which includes Inventories of
176.342 euro, Receivables of
265.748 euro and cash availability of
32.371 euro.
The company's Equity was valued at
-77.974 euro, while total Liabilities amounted to
560.006 euro.
Equity decreased by -94.037 euro, from 16.153 euro in 2023, to -77.974 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Nordpharm Ab S.r.l.